Highlights Magle Chemoswed Holding AB

Equities

MAGLE

SE0014401014

Delayed Nasdaq Stockholm Other stock markets 08:54:45 23/05/2024 pm IST			5-day change	1st Jan Change
33.2 ^SEK	-1.19%		+2.47%	+31.75%

18/04	Magle Chemoswed Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
22/03	Magle Chemoswed Holding AB (OM:MAGLE) made a tender to acquire 99.96% stake in Amniotics AB (OM:AMNI) from LSCS Invest AB, Deflexum AB, Marcus Larsson and other for SEK 10.9 million.	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Magle Chemoswed Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024	18/04	CI
Magle Chemoswed Holding AB Resolves to Withdraws Dividend Proposal for the Year 2023	22/03	CI
Magle Chemoswed Holding AB (OM:MAGLE) made a tender to acquire 99.96% stake in Amniotics AB (OM:AMNI) from LSCS Invest AB, Deflexum AB, Marcus Larsson and other for SEK 10.9 million.	22/03	CI
Magle Chemoswed Holding AB Proposes Dividend for the Fiscal Year 2023	16/02	CI
Magle Chemoswed Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	16/02	CI
Magle Chemoswed Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023	16/02	CI
Magle Group Enters Collaboration with Sirtex Medical to Support the International Commercialization of Embocept S Dsm 50 Um	08/23/08	CI
Magle Chemoswed Holding AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	30/23/30	CI
Magle Chemoswed Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2023	30/23/30	CI
Magle Group Announces Positive Results from Post-Market Clinical Follow-Up of SmartPAN	27/23/27	CI
Magle Chemoswed Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	16/23/16	CI
Magle Chemoswed Holding AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	16/23/16	CI
Magle Chemoswed Holding AB Reports Earnings Results for the Full Year Ended December 31, 2022	16/23/16	CI
Magle Chemoswed Holding AB 's Proprietary Product Axxo® Woundgel Receives Regulatory Approval in Kuwait	21/22/21	CI
Magle Group's Vascular Embolic Product Embocept® S Receives Regulatory Approval in Argentina	17/22/17	CI
Magle Chemoswed Holding AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	30/22/30	CI
Magle Chemoswed Holding AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	30/22/30	CI
Magle Group Announces First Patients Enrolled in a Post-Market Study of Medical Device SmartPAN®	11/22/11	CI
Magle Chemoswed Holding AB Announces Post Market Clinical Study for SmartPAN®	13/22/13	CI
Magle Chemoswed Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2022	30/22/30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Magle Chemoswed Holding AB

Equities

MAGLE

SE0014401014

Highlights

Filters